Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
Amorim G, Jaworski J, Yang J, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Turner M, Andrade BB, Velez Edwards DR, Santos AR, Rolla VC, Sterling TR, Haas DW; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Amorim G, et al. Among authors: jaworski j. Pharmacogenet Genomics. 2024 Oct 15. doi: 10.1097/FPC.0000000000000552. Online ahead of print. Pharmacogenet Genomics. 2024. PMID: 39470346
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
Amorim G, Jaworski J, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Turner M, Andrade BB, Velez Edwards DR, Santos AR, Rolla VC, Sterling TR, Haas DW; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Amorim G, et al. Among authors: jaworski j. medRxiv [Preprint]. 2023 Sep 1:2023.08.30.23294860. doi: 10.1101/2023.08.30.23294860. medRxiv. 2023. Update in: Pharmacogenet Genomics. 2024 Oct 15. doi: 10.1097/FPC.0000000000000552 PMID: 37693472 Free PMC article. Updated. Preprint.
Expanding the genetic landscape of endometriosis: Integrative -omics analyses uncover key pathways from a multi-ancestry study of over 900,000 women.
Guare LA, Das J, Caruth L, Rajagopalan A, Akerele AT, Brumpton BM, Chen TT, Kottyan L, Lin YF, Moreno E, Mulford AJ, Rovite V, Sanders AR, Dombrovska MS, Elhadad N, Hill A, Jarvik G, Jaworski J, Luo Y, Namba S, Okada Y, Shi Y, Shirai Y, Shortt J, Wei WQ, Weng C, Yamamoto Y, Chapman S, Zhou W, Velez Edwards DR, Setia-Verma S. Guare LA, et al. Among authors: jaworski j. medRxiv [Preprint]. 2024 Nov 29:2024.11.26.24316723. doi: 10.1101/2024.11.26.24316723. medRxiv. 2024. PMID: 39649588 Free PMC article. Preprint.
Identifying a Genetic Link Between Lung Function and Psoriasis.
Tanimura K, Aldrich MC, Jaworski J, Xing J, Okawa S, Chandra D, Nouraie SM, Nyunoya T. Tanimura K, et al. Among authors: jaworski j. Ann Hum Genet. 2024 Dec 24. doi: 10.1111/ahg.12587. Online ahead of print. Ann Hum Genet. 2024. PMID: 39718377
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy.
Wang T, Campbell C, Stockdale AJ, Todd S, McIntyre K, Frankland A, Jaworski J, Glampson B, Papadimitriou D, Mercuri L, Mayer E, Jones CR, Salih H, Roadknight G, Little S, Noble T, Várnai KA, Davis C, Heinson AI, George M, Borca F, English L, Romão L, Ramlakhan D; NIHR HIC Viral Hepatitis and Liver Disease Consortium; Woods K, Davies J, Nastouli E, Khakoo SI, Gelson W, Cooke GS, Barnes E, Matthews PC. Wang T, et al. Among authors: jaworski j. JHEP Rep. 2024 Oct 9;7(1):101229. doi: 10.1016/j.jhepr.2024.101229. eCollection 2025 Jan. JHEP Rep. 2024. PMID: 39717508 Free PMC article.
Turncoat antibodies unmasked in a model of autoimmune demyelination: from biology to therapy.
Taghipour-Mirakmahaleh R, Morin F, Zhang Y, Bourhoven L, Béland LC, Zhou Q, Jaworski J, Park A, Dominguez JM, Corbeil J, Flanagan EP, Marignier R, Larochelle C, Kerfoot S, Vallières L. Taghipour-Mirakmahaleh R, et al. Among authors: jaworski j. bioRxiv [Preprint]. 2024 Dec 6:2024.12.03.623846. doi: 10.1101/2024.12.03.623846. bioRxiv. 2024. PMID: 39677612 Free PMC article. Preprint.
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47.
Smolen JS, Trefler J, Racewicz A, Jaworski J, Zielińska A, Krogulec M, Jeka S, Wojciechowski R, Kolossa K, Dudek A, Krajewska-Włodarczyk M, Hrycaj P, Klimiuk PA, Burmester GR, Kim S, Bae Y, Yang G, Jung Y, Hong J, Keystone E. Smolen JS, et al. Among authors: jaworski j. RMD Open. 2024 Oct 18;10(4):e004514. doi: 10.1136/rmdopen-2024-004514. RMD Open. 2024. PMID: 39424404 Free PMC article. Clinical Trial.
454 results